Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers
Year: 2014
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Human leukocyte telomere length (LTL) decreases with age and shorter LTL has previously been associated with increased prospective mortality. However, it is not clear whether LTL merely marks the health status of an individual by its association with parameters of immune function, for example, or whether telomere shortening also contributes causally to lifespan variation in humans. METHODS: We measured LTL in 870 nonagenarian siblings (mean age 93 years), 1580 of their offspring and 725 spouses thereof (mean age 59 years) from the Leiden Longevity Study (LLS). RESULTS: We found that shorter LTL is associated with increased prospective mortality in middle (30-80 years; hazard ratio (HR)=0.75, P=0.001) and highly advanced age (≥90 years; HR=0.92, P=0.028), and show that this association cannot be explained by the association of LTL with the immune-related markers insulin-like growth factor 1 to insulin-like growth factor binding protein 3 molar ratio, C-reactive protein, interleukin 6, cytomegalovirus serostatus or white blood cell counts. We found no difference in LTL between the middle-aged LLS offspring and their spouses (β=0.006, P=0.932). Neither did we observe an association of LTL-associated genetic variants with mortality in a prospective meta-analysis of multiple cohorts (n=8165). CONCLUSIONS: We confirm LTL to be a marker of prospective mortality in middle and highly advanced age and additionally show that this association could not be explained by the association of LTL with various immune-related markers. Furthermore, the approaches performed here do not further support the hypothesis that LTL variation contributes to the genetic propensity for longevity.
DOI: 10.1093/ije/dyt267
Authors: Joris Deelen, Marian Beekman, Veryan Codd, Stella Trompet, Linda Broer, Sara Hägg, Krista Fischer, Peter E Thijssen, H Eka D Suchiman, Iris Postmus, André G Uitterlinden, Albert Hofman, Anton J M de Craen, Andres Metspalu, Nancy L Pedersen, Cornelia M van Duijn, J Wouter Jukema, Jeanine J Houwing-Duistermaat, Nilesh J Samani, P Eline Slagboom
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,514
Funders: John D. and Catherine T. MacArthur Foundation, Bristol-Myers Squibb, Vårdalstiftelsen, Network for Studies on Pensions, Aging and Retirement, National Institute for Health and Care Research, British Heart Foundation, European Commission, Stiftelsen för Strategisk Forskning, Eesti Teadusfondi, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Vetenskapsrådet, Tartu Ülikool, Centre for Medical Systems Biology, National Institutes of Health, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: G1028663679, G1077033501, G1495020029, GENETIC AND ENVIRONMENTAL INFLUENCES IN BEHAVIORAL AGING, G178382592, G218565478, G2238725043, Causal inference methodology for studies involving conventional and Mendelian randomization, Interstitial Cystitis in Swedish Twins, G2476663878, tweeling onderzoek, met een focus op gedrag en depressie, G3207356259, G3227761751, G3588481721, G3839646794, G393177772, G3995246868, Cholesterol metabolism pathway: Cognitive change and Alzheimer's disease risk, G431860981, G4486034022, European Network for Genetic and Genomic Epidemiology, G5702163051, G5862741731, Genetic & Environmental Influences-Biobehavioral Aging, Integrated research on DEvelopmental determinants of Aging and Longevity, G6007406412, G6087908568, G6091493096, G6994344002, Twin-family database for behavior genetics and genomics studies, DEMENTIA IN SWEDISH TWINS, G7689122240, A PHArmacogenomic study of Statins in the Elderly at risk for cardiovascular disease, G83699068, G843111023, G8776062500, G915891724
OpenAlex ID: W2144008778
